Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Clinical trial NCT05698979 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05698979
- Sponsor
- University Hospital, Toulouse
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2028-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.